Navigation Links
Lilly and the Juvenile Diabetes Research Foundation Partner to Fund Regenerative Medicine Research in Type 1 Diabetes
Date:2/3/2011

INDIANAPOLIS and NEW YORK, Feb. 3, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and the Juvenile Diabetes Research Foundation (JDRF) today announced that they have signed an agreement to fund early-stage research that could enable patients with type 1 diabetes to regenerate insulin-producing cells destroyed by the disease.

"The goal of this research agreement is to understand how selected cells can be reprogrammed in order to convert them into insulin-producing cells in the body," said Philip Larsen, M.D., Ph.D., chief scientific officer for diabetes drug discovery at Lilly. "This research is an example of regenerative medicine, a new frontier in science that replaces or regenerates new cells, tissues or organs, and while this particular research is early stage, it may ultimately lead to new approaches to treating type 1 diabetes."

Type 1 diabetes is an autoimmune disease in which the body's immune system attacks and destroys the beta cells, stopping a person's pancreas from producing insulin. Insulin is a hormone that enables people to get energy from food. According to JDRF, in the U.S. alone, as many as three million people have type 1 diabetes.(1)

One research approach to finding novel treatments for type 1 diabetes may be to restore insulin production by regenerating insulin-producing cells within a person's body. This involves triggering the body to grow its own new beta cells, either by growing existing ones – some are usually still active, even in people who have had diabetes for decades – or by creating new ones by reprogramming, which involves converting one type of cell in the body into a different type.  If a therapeutic is developed that will allow for the regeneration of beta cells, it could potentially eliminate the need for insulin.  

The JDRF-Lilly agreement will support a three-year, $1.4 million pre-cli
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014 The western European automated endoscope ... largely a replacement market with fewer new installations ... and partnerships are redefining competitive landscape in western ... provides details about revenue forecasts, unit shipments, market ... the country. The changing landscape makes it important ...
(Date:9/22/2014)... , September 22, 2014 ... http://www.researchandmarkets.com/research/8ndtrc/freeze_drying_ ) has announced the addition of ... (Lab, Pilot, & Industrial) Market - Forecast ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,The global freeze ... in 2014 and is expected to reach ...
(Date:9/22/2014)... September 22, 2014 Final ... 25   The second edition of the ... excited to announce the final nominations for the 2014 ... on the evening of September 25 at The Taj Mahal Palace, ... applicants based on a variety of qualitative and quantitative ...
Breaking Medicine Technology:Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 2Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 3Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 2Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 3
...  SuccessEHS announces that its newest release will increase physician ... to previous releases.  The company has optimized features and ... and Practice Management software solution to make ... will focus on user efficiency and physician productivity ...
...  Snow tires? Check! Anti-freeze? Check! Window scraper? Check! Gloves? ... to prepare your skin for the effects of winter. ... skin that is rough, flaky, and downright unsightly. This ... it starts with AmLactin® Moisturizing Body Lotion. Wrap yourself ...
Cached Medicine Technology:Newest SuccessEHS Release to Increase Physician Software Usability 2Newest SuccessEHS Release to Increase Physician Software Usability 3Don't Let Your Skin Take a Backseat As You Prepare for Winter 2Don't Let Your Skin Take a Backseat As You Prepare for Winter 3
(Date:9/22/2014)... On Saturday, September 27, UHY LLP and UHY Cares ... is doing an amazing job helping kids and refurbishing school ... and friends will be spending the day at Academy of ... graphics, as well as clean the playground and surrounding park ... in May but due to weather conditions it was postponed ...
(Date:9/22/2014)... Sept. 22, 2014 (HealthDay News) -- Teens and young ... "intensive" behavioral counseling to help prevent risky sexual behaviors, ... Task Force. Every year, about 20 million new ... in the United States. About half involve people between ... force. Its new report, published Sept. 22 ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, ... newborn intensive care units (NICU) set up private rooms for ... finds. Researchers at one children,s hospital found that preemies ... when their NICU switched from the traditional "open-bay" layout to ... 22 in the journal Pediatrics , add to evidence ...
(Date:9/22/2014)... Malaysia today became a founding partner in the Global ... to promoting young talent in science, technology, engineering and ... New York Academy of Sciences (NYAS), Malaysian Prime Minister ... Monday Sept. 22. , With the goal of developing ... countries by 2020, the initiative will create a host ...
(Date:9/22/2014)... Recent two-generation approaches to reducing poverty that help ... from researchers, advocates, and foundations. By combining education ... move to jobs that offer a path out ... for children, these programs aim to improve the ... a new report from the National Center for ...
Breaking Medicine News(10 mins):Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 3Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:A two-generation lens: Current state policies fail to support families with young children 2
... Updated Information Provided to Customers , LANDOVER, Md., Jan. ... to pull products containing peanut butter and peanut paste ... has traced the salmonella to a plant owned by ... recalled products from our shelves including:, ...
... The association between tobacco smoke and cancer deaths ... by a recent study from a UC Davis researcher, ... lives than previously estimated. , The epidemiological analysis, published ... more than 70 percent of the cancer death burden ...
... /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) www.htdsmedical.com ... CEO. Terry is the current President and CEO of Shenzhen ... , a company targeted for a merger with HTDS. (See ... filings on Pink Sheets shortly. , Mr. Terry Yuan will ...
... to 50 million uninsuredsteeply rising insurance premiumsemployers cutting ... picture. In Disease, Diagnoses, and Dollars: Facing the ... Robert Kaplan takes America,s healthcare industry to task ... in it. , Provocative, timely, and comprehensively researched, ...
... MIAMI, Jan. 21 Financial services leader ING and the ... contest that,celebrates their success in the ING Run For Something ... The top three essays were submitted by ... Dade Middle School, 7th grade, -- Christian ...
... Favorite Body Parts: Our Faces are Fabulous; Tummies ... abs top the list of favorite and least favorite ... to a new survey conducted by American Laser Centers, ... U.S.Nearly a quarter of the men (24 percent) and ...
Cached Medicine News:Health News:Giant Food Responds to Recall of Peanut Based Products 2Health News:UC Davis study links smoking with most male cancer deaths 2Health News:Hard To Treat Diseases (HTDS) To Name New CEO and Directors 2Health News:ING and Fit Miami Foundation Name Winners of 'ING Run For Something Better' Student Essay Contest 2Health News:ING and Fit Miami Foundation Name Winners of 'ING Run For Something Better' Student Essay Contest 3Health News:ING and Fit Miami Foundation Name Winners of 'ING Run For Something Better' Student Essay Contest 4Health News:How Does Our Vanity Fare? 2
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
Minimal M9CA Broth...
Form: Cream-colored powder Moisture: 10% Ash: 6.5% Gel Strength (1.5%): 550 950 gm/cm 2 Gel pH (1.5%): 6.0 7.5 Gel Point (1.5%): 34 38C Melting Point (1.5%): 84 88C Application: Bacterial ...
...
Medicine Products: